Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

Abstract

In situ BRCA1-related expression parameters could be used for clinical purposes at the time of diagnosis. In contrast, miR-548c-5p showed a promising potential as a prognostic factor in TNBC.